Artivion (AORT) Net Cash Flow (QoQ) (2010 - 2026)
Artivion (AORT) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.32 Bn | 174.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.59 Bn | 125.71 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.77 Bn | 66.32 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.46 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.15 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.20 Bn | - |
| 9 | Koninklijke Philips | 25.24 Bn | 22.11 Bn | 2.07 Bn |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.33% |
| Dec 31, 2025 | -142.65% |
| Sep 30, 2025 | 39.44% |
| Jun 30, 2025 | 186.00% |
| Mar 31, 2025 | -1,397.66% |
| Dec 31, 2024 | -148.58% |
| Sep 30, 2024 | -33.48% |
| Jun 30, 2024 | 141.13% |
| Mar 31, 2024 | -227.96% |
| Dec 31, 2023 | 53.68% |
| Sep 30, 2023 | -73.77% |
| Jun 30, 2023 | 307.26% |
| Mar 31, 2023 | -109.03% |
| Dec 31, 2022 | -418.64% |
| Sep 30, 2022 | 110.31% |
| Jun 30, 2022 | -221.86% |
| Mar 31, 2022 | 67.50% |
| Dec 31, 2021 | -184.33% |
| Sep 30, 2021 | 347.12% |
| Jun 30, 2021 | 12.03% |